Eyeworld

SEP 2018

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1021247

Contents of this Issue

Navigation

Page 99 of 138

97 EW IN OTHER NEWS September 2018 Reference Smith M, et al. Phacoemulsification and endocyclophotocoagulation in uncontrolled glaucoma: Three-year results. J Cataract Refract Surg. 2018. Epub ahead of press. New technique for lenticule dissection in SMILE Researchers describe a new lenti- cule dissection technique for the refractive procedure small incision lenticule extraction (SMILE) in the Journal of Cataract and Refractive Surgery. Typically, the lenticule, which is formed based on two planes created by a femtosecond laser, is dissected with a spatula and removed with forceps. The meth- od described by Weng et al. uses a corneal flap separator and "a trace of balanced salt solution placed on the superficial interface of the lenti- cule" to separate the anterior plane followed by the posterior plane. Balanced salt solution was also used to wash the ocular surface around the corneal pocket incision before dissecting at each plane. The study, which involved 29 patients who had the traditional dissection technique in one eye and the liquid dissection technique in the other, found the liquid dissection technique resulted in significantly fewer corneal aber- rations within 2 hours and 1 month postop, higher contrast sensitivity at postop day 1, and smoother lenticule surfaces. "The balanced salt solution dissection technique in small-incision lenticule extraction contributes to rapid visual recov- ery," Weng et al. concluded, adding that it could make surgical time shorter with less force required for dissection. Reference Weng S, et al. Development of a liquid dis- section technique for small-incision lenticule extraction: Clinical results and ultrastructural evaluation. J Cataract Refract Surg. 2018. Epub ahead of press. EW Reference Gopinath B, et al. Dietary flavonoids and the prevalence and 15-y incidence of age-re- lated macular degeneration. Am J Clin Nutr. 2018;108:381-387. Phaco and ECP provides "modest" IOP reduction in uncontrolled glaucoma Three-year study results of the IOP-lowering effects of phacoemul- sification combined with endocyclo- photocoagulation (ECP) in eyes that had not had prior glaucoma surgery showed a mean 25% reduction in IOP (18.7 mm Hg preoperatively to 14 mm Hg), according to research published in the Journal of Cataract and Refractive Surgery. Smith et al. described this as a "modest but significant drop in IOP." This effect, the study authors acknowledged, is less than that of trabeculectomy or tubes and how it compares to micro- invasive glaucoma surgery (MIGS) options is "uncertain." While ECP and phaco did not have any serious side effects, Smith et al. noted that 60% of the procedures were classi- fied as "failures" by the 3-year mark, which meant they either (1) had an IOP higher than 21 mm Hg, an IOP lower than 6 mm Hg, or did not reach at least a 20% reduction from baseline after 1, 2, or 3 years postop; or (2) or needed further surgery to reduce IOP within the study period. days, in addition to daily use (five times daily) of hyaluronic acid, and 15 control patients who only used hyaluronic acid five times per day during the study period. Those who received the platelet plasma injections showed reduced corneal staining, increased Schirmer scores (5.6±0.7 to 9.0±1.1 mm), increased tear break-up time (4.0±0.4 to 6.4±0.4) at 90 days, and improved ocular surface disease index scores. "This [represents] a novel alternative treatment for severe dry eye," Avila et al. wrote. Reference Avila MY, et al. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. Br J Ophthalmol. 2018. Epub ahead of print. Orange consumption and macular degeneration A study of Australian adults 50 and older followed over 15 years revealed that those who ate at least one serving of oranges daily had a 60% reduced risk of developing macular degeneration. "The data shows that flavonoids found in or- anges appear to help protect against the disease," Bamini Gopinath, PhD, associate professor, Westmead Institute for Medical Research, said in a press release. "Flavonoids are powerful antioxidants found in almost all fruits and vegetables, and they have important anti-inflamma- tory benefits for the immune sys- tem," Dr. Gopinath continued. "We examined common foods that con- tain flavonoids such as tea, apples, red wine, and oranges. Significantly, the data did not show a relationship between other food sources protect- ing the eyes against the disease." Herpes zoster vaccination rates "remain relatively low" Though the U.S. Centers for Disease Control and Prevention recom- mends healthy adults 50 years and older receive the herpes zoster vaccine, a paper published in Cornea revealed physician attitudes and practices with this vaccination are low compared to other vaccinations recommended for this age group. A cross-sectional online survey of physicians conducted from January–March 2017 at the New York University Langone Hospital Division of General Internal Medi- cine and Clinical Innovation in five practice settings (response rate 26%; 138 respondents out of 530 con- tacted) showed that 93% and 94% of physicians agree that influenza and pneumococcal vaccination, respectively, are clinical priorities, while 76% agreed with the clinical priority of zoster vaccination. Only 35% said they "strongly agree" with the importance of zoster vaccina- tion, compared to 68% and 74% who strongly agree with the clinical importance of pneumococcal and influenza vaccination. In terms of the zoster vaccine in practice, the survey found that physicians esti- mated 43% of healthy patients 60 or older received the zoster vaccine, and 11% of patients 50–60 were vaccinated with it. "[Herpes zoster] vaccination rates remain relatively low compared with rates of influ- enza and pneumonia vaccination," Tsui et al. wrote, adding that there is a need for stronger recommenda- tions by primary care physicians for the zoster vaccine. Reference Tsui E, et al. Evaluating physician attitudes and practices regarding herpes zoster vacci- nation. Cornea. 2018;37:947–51. Novel, platelet-rich plasma injections treat severe dry eye A small study of patients with Sjögren's syndrome who had severe dry eye evaluated the use of plate- let-rich plasma injections, finding them to be "safe and effective in improving tear parameters as well as subjective parameters," according to Avila et al. The research published in the British Journal of Ophthalmology included 15 patients who received four injections at 0, 30, 60, and 90 News in brief If you're interested in reading more timely news briefs like these, subscribe to EyeWorld Weekly Update, our free newsletter emailed every Friday, by contacting eyeworld@eyeworld.org.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2018